好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

NeuroBytes: A new rapid, high-yield, nationwide e-Learning platform for continuing professional development in neurology
General Neurology
S51 - General Neurology: Models of Clinical Care and Disease (2:00 PM-2:12 PM)
006

A sustainable continuing professional development (CPD) system is vital in neurology due to the field’s expanding therapeutic options, multiple subspecialties, and vulnerable patient populations. In an effort to offer concise, evidence-based CPD updates to a wide range of neurology professionals, the AAN launched NeuroBytes in 2018. NeuroBytes are brief (<5 min) multimedia videos that provide high-yield, topic-specific updates to AAN members.

To assess the feasibility, usability, target audience, and effectiveness of NeuroBytes, a bite-sized (<5 min) asynchronous e-Learning program for delivering continuing education to neurology providers.

NeuroBytes was beta tested from August–December 2018 and subsequently launched for pilot circulation from January–April 2019. Usage was assessed by quantifying course enrollment and completion rates; feasibility by quantifying the cost and time required to design and release a module; appeal by user satisfaction scores; and effectiveness by self-reported change in practice.

A total of 5,130 NeuroBytes member enrollments (1,026+551/month) occurred from January 11–May 28, 2019 with a median of 588 enrollments per module (interquartile range, 194-922) and 37% course completion. The majority of viewers were neurologists (54%) followed by neurologists in training (26%) and students (8%). NeuroBytes took 59 hours to develop at an estimated $77.94/hour. Of the 1,895 users who completed the survey, 82% were “extremely likely” or “very likely” to recommend NeuroBytes to a colleague and 60% agreed that the depth of educational content was “just right.” Only 29% of viewers responded that NeuroBytes would change how they managed many of their patients.

NeuroBytes is a user-friendly, cost-effective CPD product that delivers concise and relevant updates to a broad range of neurology practitioners and trainees. Future efforts will explore models where NeuroBytes targets patient or trainee audiences and combines with other CPD programs to impact the quality of training, patient care, and clinical practice.

Authors/Disclosures
Laura E. Lavette (Wake Forest School of Medicine)
PRESENTER
No disclosure on file
Alexandra M. Miller, MD (NYU Langone Department of Neurology) Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Modifi Biosciences.
Zachary N. London, MD, FAAN (University of Michigan) Dr. London has nothing to disclose.
Veronica E. Santini, MD, MA, FAAN Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion NeuroStim, Inc. The institution of Dr. Santini has received research support from MeiraGTx, LLC. The institution of Dr. Santini has received research support from Ono Pharmaceuticals. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with 好色先生. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with International Parkinson and Movement Disorders Society. Dr. Santini has received personal compensation in the range of $0-$499 for serving as a invited speaker with Parkinson Study Group. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a data safety monitoring board with NIH.
Ilana M. Ruff, MD Dr. Ruff has nothing to disclose.
Jeff Kraakevik, MD, FAAN Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Amanda Chamberlain (好色先生) No disclosure on file
Beth Rogers-Baggett (好色先生) No disclosure on file
Calli L. Cook, DNP, FNP-C, FAAN (Emory Healthcare) Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Alexander Merkler, MD Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Robert A. Rook (好色先生) Mr. Rook has nothing to disclose.
Don B. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for 好色先生.
Wayne E. Anderson, DO, FAAN An immediate family member of Dr. Anderson has received personal compensation for serving as an employee of Gilead Sciences. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for occasional claims.
Stacy L. Johnson, NP (Fort Wayne Neurological Center) Ms. Johnson has nothing to disclose.
Joan Sweeney, MD Dr. Sweeney has nothing to disclose.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Isaacson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Roy E. Strowd III, MD, FAAN (Wake Forest School Of Medicine) Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.